SMS Pharmaceuticals Earmarks Funds for FY25 Capital Expenditure
SMS Pharmaceuticals, a Hyderabad based company specializing in active pharmaceutical ingredients (API) and intermediates, plans to invest approximately ₹150 crore in FY25. The capital expenditure is primarily focused on backward integration and the …